Somatic mutations in myeloid transcription factors and in activated signaling genes predict the risk of treatment failure and progression to advanced phase in chronic myeloid leukemia
Dennis Dong Huan Kim(University Health Network), Jiří Mayer(Central European Institute of Technology), Anežka Kvetková(Masaryk University), Zhaolei Zhang(University of Toronto), Mark D. Minden(University Health Network), Ivana Ježíšková(Masaryk University), Kátia Bórgia Barbosa Pagnano(Universidade Estadual de Campinas (UNICAMP)), José‐Mario Capo‐Chichi(University Health Network), María Agustina Perusini(University Health Network), Daniela Žáčková(Masaryk University), Jessie J.F. Medeiros(Ontario Institute for Cancer Research), Andrea Arruda(University Health Network), Kyoung Ha Kim(Soonchunhyang University Hospital Seoul), Youngseok Yoo(Princess Margaret Cancer Centre), Tae‐Hyung Kim(Memorial Sloan Kettering Cancer Center), Hyewon Lee(Princess Margaret Cancer Centre), Jaeyoon Kim(LG (United States)), Myung Hee Chang(Hanyang University), Carolina Pavlovsky(Unknown), Tomáš Jurček(Masaryk University), Seongyoon Yi(Princess Margaret Cancer Centre), Sagi Abelson(Ontario Institute for Cancer Research)
Cited by 0